Dr. Kenneth Gerenraich Joins Board of Directors for Satori World Medical
SAN DIEGO - July 18, 2013 - Satori World Medical
, the leader in surgical tourism, announces the appointment of physician and entrepreneur, Dr. Kenneth Gerenraich
to its board of directors.
will provide strategic input and direction on the development of Satori World Medical
and the overall Satori Experience™.
Dr. Gerenraich founded Woodward Laboratories in 1992, creating at the time one of the only companies providing treatment against infections of the skin and nails.
With a scientific portfolio of 18 patents awarded and 13 patents pending, Woodward Laboratories
evolved into a leading international antimicrobial dermatological company serving the OTC pharmaceutical, cosmetic, hospitality, sanitation, medical, and veterinary industries.
In 2010, Woodward Laboratories
was successfully sold to Pacific World
, a $300 million privately held corporation.
A physician and entrepreneur, Dr. Gerenraich earned his Bachelor's degree from Wayne State University and his Doctorate of Podiatric Medicine from the Illinois College of Podiatric Medicine, now known as Dr. William M. Scholl College of Podiatric Medicine, at the Rosalind Franklin University of Medicine & Science.
He is a diplomat of the American Academy of Pain Management.
While in private practice, Dr. Gerenraich held several leadership positions at Southern California hospitals.
"I am very pleased that Dr. Gerenraich will be adding his considerable business knowledge and leadership at the Board level," said Steven Lash, president and CEO, Satori World Medical.
"Satori World Medical
is one of the most innovative medical travel companies today," said, Dr. Kenneth Gerenraich